Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update Gamal ShihaAlaa IbrahimManoj Kumar Guidelines 06 October 2016 Pages: 1 - 30
Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace Chih-Lin LinJia-Horng Kao Editorial 05 January 2017 Pages: 31 - 33
Live donor liver transplantation for alcoholic hepatitis Ashwani K. SingalPatrick S. Kamath Point of View 06 October 2016 Pages: 34 - 37
Interferon-free treatment for HCV-infected patients with decompensated cirrhosis Tatsuo Kanda Review Article 09 June 2016 Pages: 38 - 44
Epigenetic mechanisms regulating the development of hepatocellular carcinoma and their promise for therapeutics Faisal Saeed KhanIjaz AliRashid Mehmood Review Article 07 June 2016 Pages: 45 - 53
Hepatocyte-like cells derived from induced pluripotent stem cells Namita Roy-ChowdhuryXia WangJayanta Roy-Chowdhury Review Article 17 August 2016 Pages: 54 - 69
Non-invasive diagnosis of hepatic steatosis Christiane SternLaurent Castera Review Article 25 October 2016 Pages: 70 - 78
Molecular mechanisms of HBeAg in persistent HBV infection Li-Min ChenXue-Gong FanYong-Fang Jiang Original Article 18 May 2016 Pages: 79 - 86
HBV reactivation risk factors in patients with chronic HBV infection with low replicative state and resolved HBV infection undergoing hematopoietic stem cell transplantation in Korea Chung Hwan JunBan Suk KimHyeoung-Joon Kim Original Article 28 June 2016 Pages: 87 - 95
Hepatitis B virus infection in children of HBV-related chronic liver disease patients: a study of intra-familial HBV transmission Hartono GunardiMelanie Y. IskandarDavid H. Muljono Original Article 13 September 2016 Pages: 96 - 104
Subclassification of patients with intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinoma using the up-to-seven criteria and serum tumor markers Haruki KimuraKazuyoshi OhkawaKazuhiro Katayama Original Article 20 October 2016 Pages: 105 - 114
Serum-inducible protein (IP)-10 is a disease progression-related marker for non-alcoholic fatty liver disease Nozomu WadaAkinobu TakakiHiroyuki Okada Original Article 08 November 2016 Pages: 115 - 124
Glucose fluctuations reduce quality of sleep and of life in patients with liver cirrhosis Masafumi HaraguchiHisamitsu MiyaakiKazuhiko Nakao Original Article 13 September 2016 Pages: 125 - 131
Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge Serge J. ZweersElisabeth M. de VriesFrank G. Schaap Original Article Open access 30 September 2016 Pages: 132 - 140
